markets

J. Edward Moreno

2/19/25

Hims & Hers to provide at-home blood testing with new acquisition

Hims & Hers’ share price shot up more than 15% after the company announced it had acquired at-home lab testing facility Trybe Labs.

Hims & Hers, an online pharmacy best known for selling knock-off versions of weight-loss drugs made by Novo Nordisk, will now be able to support at-home blood draws to test “hormone levels, cardiac risk, stress markers, cholesterol, liver function, thyroid function, and prostate health,” the company said in a statement.

Trybe Labs sends customers a packet that includes a blood lancet, similar to those used by diabetics. Consumers then ship the samples back and wait for results.

Hims & Hers didn’t disclose how much it paid to buy Trybe Labs. The company has been on a spending spree recently: it bought an ad for the Super Bowl this month, which sparked pushback from Novo Nordisk and lawmakers, who said it made false or misleading statements about the safety and efficacy of compounded drugs.

Hims & Hers said it will use de-identified blood-testing data to develop a proprietary AI-powered system that gives patients “personalized care.”

Hims & Hers acquires at-home lab testing facility, expanding capabilities to ultimately include affordable whole body testing for subscribers

Hims & Hers acquires at-home lab testing facility, expanding capabilities to ultimately include affordable whole body testing for subscribers

Trybe Labs sends customers a packet that includes a blood lancet, similar to those used by diabetics. Consumers then ship the samples back and wait for results.

Hims & Hers didn’t disclose how much it paid to buy Trybe Labs. The company has been on a spending spree recently: it bought an ad for the Super Bowl this month, which sparked pushback from Novo Nordisk and lawmakers, who said it made false or misleading statements about the safety and efficacy of compounded drugs.

Hims & Hers said it will use de-identified blood-testing data to develop a proprietary AI-powered system that gives patients “personalized care.”

More Markets

See all Markets

Nia Warfield, Luke Kawa

Bulls on parade

Three major US stock indexes post record closing highs on the same day for the first time since November 2021

Tech was far and away the best-performing S&P 500 sector ETF, while consumer staples was at the bottom of the leaderboard.

Bull by the horns

Nvidia Intel deal implications, according to Wall Street analysts

Wall Street analysts think through the Nvidia-Intel deal

TL;DR: Huge for Intel, helpful for Nvidia, and potentially bad for AMD.

Matt Phillips4h

markets

5h

Abercrombie & Fitch gets a lift after BTIG kicks off coverage with a “buy” rating

Abercrombie & Fitch popped over 3% Thursday afternoon after BTIG initiated coverage on the stock with a “buy” rating and set a $120 price target. That’s more than 35% above current trading levels.

“While we acknowledge headwinds from a selective consumer and tough comparisons, we have confidence in A&F’s ability to return to growth as AUR [average unit retail] headwinds abate at Abercrombie, a factor well within the company’s control, while traffic and brand health remain strong,” the firm wrote in the note.

BTIG also highlighted the retailer’s California-based Hollister brand, where growth is continuing to ramp up, and that cleaner inventory management is helping the retailer avoid big markdowns. Analysts also noted that Abercrombie still trades at a discount to its peers, making the upside more compelling.

The call comes on the heels of Abercrombie’s stronger-than-expected Q2 results last month, which featured record quarterly sales and marked its 11th straight quarter of growth.

A&F shares are down 41% year to date.

markets

8h

Analyst spotlights oil refiners’ outperformance

Major US oil refiners like Valero, Marathon Petroleum, and Phillips 66 are outperforming more than 90% of the S&P 500 this year, as a surge in global supply from OPEC+ — essentially a price-setting alliance between OPEC and Russia — has put refiners in the catbird seat when it comes to price negotiations with producers.

“We continue to assess that refiners will set the price of crude and refiners will win in a wide range of scenarios for crude, making refiners the best vehicle for long petroleum exposure,” wrote Colin Fenton, head of commodities research at 22V Research.

Crack spreads, a measure of profit margins at refiners, have risen nearly 50% so far this year.

Olive Garden parent company Darden dips after serving up a Q1 earnings miss

The restaurant giant saw strong comps, but is facing higher costs and more price-conscious consumers.

Olive Garden Italian Kitchen. Olive Garden is a division of Darden Restaurants.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.

©2025 Sherwood Media, LLC